Approvals/TGA/SIFROL pramipexole dihydrochloride monohydrate 250 microgram tablet blister pack

Approved

STANDARD

SIFROL pramipexole dihydrochloride monohydrate 250 microgram tablet blister pack

Boehringer Ingelheim Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 7466e046eba975b2
Product Name: SIFROL pramipexole dihydrochloride monohydrate 250 microgram tablet blister pack
Artg Id: 66484
Artg Name: SIFROL pramipexole dihydrochloride monohydrate 250 microgram tablet blister pack
Sponsor: Boehringer Ingelheim Pty Ltd
Company Detail Path: /organization/boehringer-ingelheim-pty-ltd
Artg Date: 1999-04-20
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2012-CMI-02504-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-03631-3

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

7466e046eba975b2

Type

Standard